These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2994780)
1. Immunologic and virologic status of multitransfused patients: role of type and origin of blood products. By the AIDS-Hemophilia French Study Group. Blood; 1985 Oct; 66(4):896-901. PubMed ID: 2994780 [TBL] [Abstract][Full Text] [Related]
2. Natural history of primary infection with LAV in multitransfused patients. By the AIDS-Hemophilia French Study Group. Blood; 1986 Jul; 68(1):89-94. PubMed ID: 3013344 [TBL] [Abstract][Full Text] [Related]
3. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage. Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559 [TBL] [Abstract][Full Text] [Related]
4. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic. Evatt BL; Gomperts ED; McDougal JS; Ramsey RB N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095 [TBL] [Abstract][Full Text] [Related]
5. A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses. Stein SF; Evatt BL; McDougal JS; Lawrence DN; Holman RC; Ramsey RB; Spira TJ Blood; 1985 Oct; 66(4):973-9. PubMed ID: 2994784 [TBL] [Abstract][Full Text] [Related]
7. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors. Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947 [TBL] [Abstract][Full Text] [Related]
8. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States. Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787 [TBL] [Abstract][Full Text] [Related]
9. Abnormalities of lymphocyte subsets and anti-LAV/HTLV-III status in Greek hemophiliacs. Choremi H; Economidou J; Psarra K; Sidiri E; Mandalaki T; Louizou C; Gialeraki A; Markakis C; Papaevangelou C; Kallinicos G AIDS Res; 1986; 2(4):271-7. PubMed ID: 3101712 [TBL] [Abstract][Full Text] [Related]
10. HTLV III antibodies and immunological alterations in hemophilia patients. Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759 [TBL] [Abstract][Full Text] [Related]
11. Antibodies to HIV in Israeli hemophiliacs: relationship between serological profile and disease development. Orgad S; Malone G; Zaizov R; Marinowitz U; McLane MF; Umiel T; Cohen IJ; Vogel R; Cohen-Avishai O; Ramot B AIDS Res Hum Retroviruses; 1987; 3(3):323-32. PubMed ID: 3124874 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C infection in children with hemophilia A and B. Blanchette VS; Vorstman E; Shore A; Wang E; Petric M; Jett BW; Alter HJ Blood; 1991 Jul; 78(2):285-9. PubMed ID: 1712646 [TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G antibodies to lymphadenopathy-associated virus in differently treated French and Belgian hemophiliacs. Rouzioux C; Brun-Vezinet F; Couroucé AM; Gazengel C; Vergoz D; Desmyter J; Vermylen J; Vermylen C; Klatzmann D; Geroldi D Ann Intern Med; 1985 Apr; 102(4):476-9. PubMed ID: 2983593 [TBL] [Abstract][Full Text] [Related]
14. Distribution of the level of antibody to AIDS-associated virus (LAV) in sera from AIDS or AIDS related complex and Japanese hemophiliacs infected with AIDS-associated virus. Tsuchie H; Kawatani T; Nakayama E; Matsui T; Kurimura T; Hinuma Y Microbiol Immunol; 1985; 29(11):1083-7. PubMed ID: 2869397 [TBL] [Abstract][Full Text] [Related]
15. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household]. Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827 [TBL] [Abstract][Full Text] [Related]
16. Clinical and serological study of the human immunodeficiency virus infection in a cohort of multitransfused persons. Mokhbat JE; Naman RE; Rahme FS; Farah AE; Zahar KL; Maalouf A J Med Liban; 1989; 38(1):9-14. PubMed ID: 2519339 [TBL] [Abstract][Full Text] [Related]
17. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients. Abe T AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan. Ikegami N AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX. Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059 [TBL] [Abstract][Full Text] [Related]
20. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients. Heimburger N; Karges HE; Weidmann E Dev Biol Stand; 1987; 67():303-10. PubMed ID: 3038638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]